These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

580 related items for PubMed ID: 15776319

  • 1. Earliest clinical manifestations and natural history of neurofibromatosis type 2 (NF2) in childhood: a study of 24 patients.
    Ruggieri M, Iannetti P, Polizzi A, La Mantia I, Spalice A, Giliberto O, Platania N, Gabriele AL, Albanese V, Pavone L.
    Neuropediatrics; 2005 Feb; 36(1):21-34. PubMed ID: 15776319
    [Abstract] [Full Text] [Related]

  • 2. Infantile onset neurofibromatosis type 2 presenting with peripheral facial palsy, skin patches, retinal hamartoma and foot drop.
    Tibussek D, Hübsch S, Berger K, Schaper J, Rosenbaum T, Mayatepek E.
    Klin Padiatr; 2009 Feb; 221(4):247-50. PubMed ID: 19629903
    [Abstract] [Full Text] [Related]

  • 3. Ophthalmologic findings and long-term course in patients with neurofibromatosis type 2.
    Bosch MM, Boltshauser E, Harpes P, Landau K.
    Am J Ophthalmol; 2006 Jun; 141(6):1068-1077. PubMed ID: 16765675
    [Abstract] [Full Text] [Related]

  • 4. Concordance of bilateral vestibular schwannoma growth and hearing changes in neurofibromatosis 2: neurofibromatosis 2 natural history consortium.
    Fisher LM, Doherty JK, Lev MH, Slattery WH.
    Otol Neurotol; 2009 Sep; 30(6):835-41. PubMed ID: 19704365
    [Abstract] [Full Text] [Related]

  • 5. Neurofibromatosis type 2 in an infant with multiple plexiform schwannomas as first symptom.
    Miyakawa T, Kamada N, Kobayashi T, Hirano K, Fujii K, Sasahara Y, Nagai Y, Shinkai H.
    J Dermatol; 2007 Jan; 34(1):60-4. PubMed ID: 17204104
    [Abstract] [Full Text] [Related]

  • 6. Management strategies in neurofibromatosis type 2.
    Moffat DA, Quaranta N, Baguley DM, Hardy DG, Chang P.
    Eur Arch Otorhinolaryngol; 2003 Jan; 260(1):12-8. PubMed ID: 12520350
    [Abstract] [Full Text] [Related]

  • 7. [Neurofibromatosis type 2 (central neurofibromatosis or bilateral acoustic neuromas, vestibular schwannomas): from phenotype to gene].
    Sabol Z, Kipke-Sabol L, Miklić P, Hajnsek-Propadalo S, Sabol F.
    Lijec Vjesn; 2006 Jan; 128(9-10):309-16. PubMed ID: 17128670
    [Abstract] [Full Text] [Related]

  • 8. Plasminogen activation in neurofibromatosis 2-associated and sporadic schwannomas.
    Sirén V, Antinheimo JP, Jääskeläinen J, Böhling T, Carpén O, Vaheri A.
    Acta Neurochir (Wien); 2004 Feb; 146(2):111-8. PubMed ID: 14963743
    [Abstract] [Full Text] [Related]

  • 9. Infratentorial meningioma in an 8-year-old child as first sign of neurofibromatosis type 2.
    Stettner GM, Rostasy KM, Ludwig HC, Merkler D, Fahsold R, Gärtner J.
    Neuropediatrics; 2007 Feb; 38(1):29-31. PubMed ID: 17607601
    [Abstract] [Full Text] [Related]

  • 10. Outcome from surgery for vestibular schwannomas in children.
    MacNally SP, Rutherford SA, King AT, Freeman S, Thorne J, Mawman D, O'Driscoll MP, Evans DG, Ramsden RT.
    Br J Neurosurg; 2009 Jun; 23(3):226-31. PubMed ID: 19533454
    [Abstract] [Full Text] [Related]

  • 11. [Neurofibromatosis type 2 and auditory brainstem implantation].
    Elvsåshagen T, Solyga V, Bakke SJ, Heiberg A, Kerty E.
    Tidsskr Nor Laegeforen; 2009 Aug 13; 129(15):1469-73. PubMed ID: 19690597
    [Abstract] [Full Text] [Related]

  • 12. Further genotype--phenotype correlations in neurofibromatosis 2.
    Selvanathan SK, Shenton A, Ferner R, Wallace AJ, Huson SM, Ramsden RT, Evans DG.
    Clin Genet; 2010 Feb 13; 77(2):163-70. PubMed ID: 19968670
    [Abstract] [Full Text] [Related]

  • 13. Skin abnormalities in neurofibromatosis 2.
    Mautner VF, Lindenau M, Baser ME, Kluwe L, Gottschalk J.
    Arch Dermatol; 1997 Dec 13; 133(12):1539-43. PubMed ID: 9420538
    [Abstract] [Full Text] [Related]

  • 14. Neurological complications involving the central nervous system in neurofibromatosis type 1.
    Hsieh HY, Wu T, Wang CJ, Chin SC, Chen YR.
    Acta Neurol Taiwan; 2007 Jun 13; 16(2):68-73. PubMed ID: 17685129
    [Abstract] [Full Text] [Related]

  • 15. [Neurofibromatosis].
    Wolkenstein P, Decq P.
    Neurochirurgie; 1998 Nov 13; 44(4):267-72. PubMed ID: 9864698
    [Abstract] [Full Text] [Related]

  • 16. Neurofibromatosis 2 (NF2): clinical characteristics of 63 affected individuals and clinical evidence for heterogeneity.
    Parry DM, Eldridge R, Kaiser-Kupfer MI, Bouzas EA, Pikus A, Patronas N.
    Am J Med Genet; 1994 Oct 01; 52(4):450-61. PubMed ID: 7747758
    [Abstract] [Full Text] [Related]

  • 17. Intrafamilial correlation of clinical manifestations in neurofibromatosis 2 (NF2).
    Zhao Y, Kumar RA, Baser ME, Evans DG, Wallace A, Kluwe L, Mautner VF, Parry DM, Rouleau GA, Joe H, Friedman JM.
    Genet Epidemiol; 2002 Oct 01; 23(3):245-59. PubMed ID: 12384977
    [Abstract] [Full Text] [Related]

  • 18. Rates of loss of heterozygosity and mitotic recombination in NF2 schwannomas, sporadic vestibular schwannomas and schwannomatosis schwannomas.
    Hadfield KD, Smith MJ, Urquhart JE, Wallace AJ, Bowers NL, King AT, Rutherford SA, Trump D, Newman WG, Evans DG.
    Oncogene; 2010 Nov 25; 29(47):6216-21. PubMed ID: 20729918
    [Abstract] [Full Text] [Related]

  • 19. Laryngeal plexiform schwannoma as first symptom in a patient with neurofibromatosis type 2.
    Nagato T, Katada A, Yoshizaki T, Kunibe I, Takahara M, Katayama A, Hayashi T, Harabuchi Y.
    Clin Neurol Neurosurg; 2010 Jul 25; 112(6):505-8. PubMed ID: 20303213
    [Abstract] [Full Text] [Related]

  • 20. Linear accelerator-based stereotactic radiosurgery for bilateral vestibular schwannomas in patients with neurofibromatosis type 2.
    Meijer OW, Vandertop WP, Lagerwaard FJ, Slotman BJ.
    Neurosurgery; 2008 May 25; 62(5 Suppl):A37-42; discussion A42-3. PubMed ID: 18580779
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.